Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ting Martin

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADARWee Loon Ong, John Nikitas, David Joseph, et al.
Clinical Genitourinary Cancer|March 21, 2026
Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder CancerBrendan L Raizenne, Vadim S Koshkin, Alec Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2023
High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical TrialTing Martin Ma, Deborah J Wong, Wanxing Chai-Ho, et al.
European Urology|November 13, 2024
Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical TrialAmar U Kishan, James M Lamb, Holly Wilhalme, et al.
Future Oncology (London, England)|September 11, 2024
Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative reviewAugust C Anderson, Joel Ho, Evan T Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2022
Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 TrialTing Martin Ma, Leslie K Ballas, Holly Wilhalme, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2025
Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapyJohn Nikitas, Ting Martin Ma, Kiri Cook, et al.
JAMA Oncology|May 15, 2025
Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical TrialJohn Nikitas, Leslie K Ballas, Tahmineh Romero, et al.
European Urology Oncology|February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional ImagingTing Martin Ma, Andrei Gafita, David Shabsovich, et al.
European Urology|September 20, 2024
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) ConsortiumWee Loon Ong, Tahmineh Romero, Soumyajit Roy, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADARWee Loon Ong, John Nikitas, David Joseph, et al.
Clinical Genitourinary Cancer|March 21, 2026
Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder CancerBrendan L Raizenne, Vadim S Koshkin, Alec Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2023
High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical TrialTing Martin Ma, Deborah J Wong, Wanxing Chai-Ho, et al.
European Urology|November 13, 2024
Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical TrialAmar U Kishan, James M Lamb, Holly Wilhalme, et al.
Future Oncology (London, England)|September 11, 2024
Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative reviewAugust C Anderson, Joel Ho, Evan T Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2022
Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 TrialTing Martin Ma, Leslie K Ballas, Holly Wilhalme, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2025
Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapyJohn Nikitas, Ting Martin Ma, Kiri Cook, et al.
JAMA Oncology|May 15, 2025
Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical TrialJohn Nikitas, Leslie K Ballas, Tahmineh Romero, et al.
European Urology Oncology|February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional ImagingTing Martin Ma, Andrei Gafita, David Shabsovich, et al.
European Urology|September 20, 2024
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) ConsortiumWee Loon Ong, Tahmineh Romero, Soumyajit Roy, et al.
Pageof 6